---
title: "SLP.US (SLP.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SLP.US/news.md"
symbol: "SLP.US"
name: "SLP.US"
parent: "https://longbridge.com/en/quote/SLP.US.md"
datetime: "2026-05-21T15:05:51.926Z"
locales:
  - [en](https://longbridge.com/en/quote/SLP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SLP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SLP.US/news.md)
---

# SLP.US (SLP.US) — Related News

### [From Engineering Intent to Validated Design in Minutes: SimScale Opens Engineering AI Agents to All Enterprise Teams](https://longbridge.com/en/news/285679447.md)
*2026-05-08T07:00:00.000Z*
> SimScale has launched its Engineering AI agents for enterprise teams, enabling organizations to automate the entire simu

### [Simulations Plus collaborates with Nvidia to accelerate drug development; stock price rises](https://longbridge.com/en/news/285384321.md)
*2026-05-06T13:02:26.000Z*
> Simulations Plus collaborates with Nvidia to develop technology that accelerates drug development, combining biological 

### [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://longbridge.com/en/news/285377120.md)
*2026-05-06T12:06:21.000Z*
> In Wednesday's pre-market session, Avalo Therapeutics (AVTX) saw a significant gain of 50.9%, reaching $24.53, while Glu

### [](https://longbridge.com/en/news/285372101.md)
*2026-05-06T11:57:06.000Z*
> Simulations Plus has reached a partnership with NVIDIA to expand GPU-accelerated artificial intelligence-assisted modeli

### [Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows | SLP Stock News](https://longbridge.com/en/news/285371800.md)
*2026-05-06T03:55:29.000Z*
> Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows | SLP Stock News

### [Sylvania Platinum's (SLP) "Buy" Rating Reiterated at Berenberg Bank](https://longbridge.com/en/news/284571132.md)
*2026-04-29T12:22:35.000Z*
> Berenberg Bank has reiterated a "buy" rating for Sylvania Platinum (LON:SLP) with a price target of GBX 166, indicating 

### [Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products | SLP Stock News](https://longbridge.com/en/news/283494231.md)
*2026-04-21T03:55:36.000Z*
> Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug 

### [Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School | SLP Stock News](https://longbridge.com/en/news/283347794.md)
*2026-04-20T03:55:44.000Z*
> Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School | SLP 

### [John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock](https://longbridge.com/en/news/283058284.md)
*2026-04-16T21:52:43.000Z*
> Simulations Plus, Inc. CRO John Anthony Dibella II sold 1,000 shares of the company's stock at an average price of $13.3

### [Simulations Plus Q2 Earnings Call Highlights](https://longbridge.com/en/news/282561011.md)
*2026-04-13T14:36:56.000Z*
> Simulations Plus (NASDAQ:SLP) reported Q2 fiscal 2026 revenue of $24.3 million, surpassing guidance, with growth in soft